Document Detail

N-brain natriuretic peptide: correlation with tricuspid insufficiency in Gaucher disease.
MedLine Citation:
PMID:  15477128     Owner:  NLM     Status:  MEDLINE    
NT-pro-brain natriuretic peptide (NT-proBNP) values are correlated with right ventricle dysfunction in pulmonary hypertension and have been recommended as a prognostic marker for symptomatic primary pulmonary hypertension. The purpose of this pilot study was to determine whether NT-proBNP values correlate with mild to moderate pulmonary hypertension in Gaucher disease. The NT-proBNP assay was performed on sera from patients with type I (non-neuronopathic) Gaucher disease who were known to have tricuspid insufficiency (TI) gradient values on echocardiography that were normal (TI<20 mmHg), borderline (TI=25-29 mmHg), or abnormal (TI>or= 30 mmHg) over time. There was a statistically significant correlation (p=0.05) between mean NT-proBNP values and TI gradient group: mean NT-proBNP for normal TI gradient (n=20 patients)=133.3 (range: 46-445)pg/ml; mean NT-proBNP for borderline TI gradient (n=17 patients)=288.7 (range: 81-1088)pg/ml; and mean NT-proBNP for elevated TI gradient (n=10 patients)=1034.2 (73-6703)pg/ml. Treatment status was not correlated with TI gradient or NT-proBNP values. Thus, in this pilot study of Gaucher disease that included patients with mild to moderate pulmonary hypertension, NT-proBNP was correlated with echocardiographic findings. Further studies will be required to ascertain if NT-proBNP can be used for diagnosis and monitoring of these patients.
Deborah Elstein; Amiram Nir; Mark Klutstein; Aya Abrahamov; Ari Zimran
Related Documents :
9630208 - Mixed connective tissue disease with severe pulmonary hypertension and extensive subcut...
831768 - Unexplained pulmonary hypertension with pulmonary arteritis in rheumatoid disease.
487838 - Structural rebuilding of pulmonary vessels at various haemodynamic shifts in the lesser...
19885388 - Therapies for scleroderma-related pulmonary arterial hypertension.
12435178 - Circumferential ultrasound ablation for pulmonary vein isolation: analysis of acute and...
10773568 - Polyurethane: material for the next generation of heart valve prostheses?
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Pulmonary pharmacology & therapeutics     Volume:  17     ISSN:  1094-5539     ISO Abbreviation:  Pulm Pharmacol Ther     Publication Date:  2004  
Date Detail:
Created Date:  2004-10-12     Completed Date:  2005-03-08     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9715279     Medline TA:  Pulm Pharmacol Ther     Country:  England    
Other Details:
Languages:  eng     Pagination:  319-23     Citation Subset:  IM    
Gaucher Clinic, Shaare Zedek Medical Center, PO Box 3235, 91031 Jerusalem, Israel.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aged, 80 and over
Biological Markers / blood
Child, Preschool
Cohort Studies
Gaucher Disease / blood*,  complications
Hypertension, Pulmonary / blood*,  etiology
Middle Aged
Natriuretic Peptide, Brain / blood*
Pilot Projects
Sensitivity and Specificity
Severity of Illness Index
Tricuspid Valve Insufficiency / blood*,  etiology
Reg. No./Substance:
0/Biological Markers; 114471-18-0/Natriuretic Peptide, Brain

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  IPL576,092, a novel anti-inflammatory compound, inhibits leukocyte infiltration and changes in lung ...
Next Document:  The infrared vibrational intensities and polar tensors of HFCO and DFCO.